TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2021/12 | 2020/12 |
Turnover |
434,633
|
243,890
|
225,847 |
Financial expenses |
1,411
|
738
|
99 |
Earnings before taxes |
7,848
|
7,164
|
5,733 |
EBITDA |
9,518
|
8,094
|
6,058 |
Total assets |
248,809
|
264,550
|
219,154 |
Current assets |
248,536
|
263,992
|
218,393 |
Current liabilities |
87,134
|
108,582
|
177,211 |
Equity capital |
46,675
|
40,968
|
35,843 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
46
|
40
|
38 |
Financial ratios
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Solvency |
18.8%
|
15.5%
|
16.4% |
Turnover per employee |
9,449
|
6,097
|
5,943 |
Profit as a percentage of turnover |
1.8%
|
2.9%
|
2.5% |
Return on assets (ROA) |
3.7%
|
3.0%
|
2.7% |
Current ratio |
285.2%
|
243.1%
|
123.2% |
Return on equity (ROE) |
16.8%
|
17.5%
|
16.0% |
Change turnover |
190,743
|
18,043
|
11,039 |
Change turnover % |
78%
|
8%
|
5% |
Chg. No. of employees |
6
|
2
|
3 |
Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.